180 related articles for article (PubMed ID: 20238479)
1. Different functional outcomes of intercellular membrane transfers to monocytes and T cells.
HoWangYin KY; Alegre E; Daouya M; Favier B; Carosella ED; LeMaoult J
Cell Mol Life Sci; 2010 Apr; 67(7):1133-45. PubMed ID: 20238479
[TBL] [Abstract][Full Text] [Related]
2. Trogocytosis-based generation of suppressive NK cells.
Caumartin J; Favier B; Daouya M; Guillard C; Moreau P; Carosella ED; LeMaoult J
EMBO J; 2007 Mar; 26(5):1423-33. PubMed ID: 17318190
[TBL] [Abstract][Full Text] [Related]
3. Membrane redistributions through multi-intercellular exchanges and serial trogocytosis.
Alegre E; Howangyin KY; Favier B; Baudhuin J; Lesport E; Daouya M; Gonzalez A; Carosella ED; Lemaoult J
Cell Res; 2010 Nov; 20(11):1239-51. PubMed ID: 20877312
[TBL] [Abstract][Full Text] [Related]
4. CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis.
Brown R; Kabani K; Favaloro J; Yang S; Ho PJ; Gibson J; Fromm P; Suen H; Woodland N; Nassif N; Hart D; Joshua D
Blood; 2012 Sep; 120(10):2055-63. PubMed ID: 22705596
[TBL] [Abstract][Full Text] [Related]
5. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells.
LeMaoult J; Caumartin J; Daouya M; Favier B; Le Rond S; Gonzalez A; Carosella ED
Blood; 2007 Mar; 109(5):2040-8. PubMed ID: 17077329
[TBL] [Abstract][Full Text] [Related]
6. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
7. HLA-G modulates immune responses by diverse receptor interactions.
Hofmeister V; Weiss EH
Semin Cancer Biol; 2003 Oct; 13(5):317-23. PubMed ID: 14708711
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
9. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.
Allan DS; Colonna M; Lanier LL; Churakova TD; Abrams JS; Ellis SA; McMichael AJ; Braud VM
J Exp Med; 1999 Apr; 189(7):1149-56. PubMed ID: 10190906
[TBL] [Abstract][Full Text] [Related]
10. Tetrameric complexes of HLA-E, HLA-F, and HLA-G.
Allan DS; Lepin EJ; Braud VM; O'Callaghan CA; McMichael AJ
J Immunol Methods; 2002 Oct; 268(1):43-50. PubMed ID: 12213342
[TBL] [Abstract][Full Text] [Related]
11. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
12. Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells.
Poupot M; Fournié JJ; Poupot R
J Leukoc Biol; 2008 Nov; 84(5):1298-305. PubMed ID: 18687904
[TBL] [Abstract][Full Text] [Related]
13. Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiation.
Camilli G; Cassotta A; Battella S; Palmieri G; Santoni A; Paladini F; Fiorillo MT; Sorrentino R
J Leukoc Biol; 2016 Jan; 99(1):121-30. PubMed ID: 26310830
[TBL] [Abstract][Full Text] [Related]
14. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
[TBL] [Abstract][Full Text] [Related]
15. The rapid induction of HLA-E is essential for the survival of antigen-activated naive CD4 T cells from attack by NK cells.
Takao S; Ishikawa T; Yamashita K; Uchiyama T
J Immunol; 2010 Nov; 185(10):6031-40. PubMed ID: 20952676
[TBL] [Abstract][Full Text] [Related]
16. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule.
Lozano JM; González R; Kindelán JM; Rouas-Freiss N; Caballos R; Dausset J; Carosella ED; Peña J
AIDS; 2002 Feb; 16(3):347-51. PubMed ID: 11834945
[TBL] [Abstract][Full Text] [Related]
17. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
[TBL] [Abstract][Full Text] [Related]
18. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation.
Pizzato N; Derrien M; Lenfant F
Hum Immunol; 2004 Nov; 65(11):1389-96. PubMed ID: 15556689
[TBL] [Abstract][Full Text] [Related]
19. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
[TBL] [Abstract][Full Text] [Related]
20. Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia.
Yan WH; Lin A; Chen BG; Luo WD; Dai MZ; Chen XJ; Xu HH; Li BL
J Cell Mol Med; 2008 Jun; 12(3):889-98. PubMed ID: 18494931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
